The active drug, alfuzosin, is used to treat symptoms of an enlarged prostate (benign prostatic hyperplasia, or BPH). Deacylated alfuzosin, also known as alfuzosin aminopropyl impurity (Alfuzosin EP Impurity D), has no therapeutic use as a drug itself; it is an inactive metabolite and an impurity standard used in pharmaceutical development and quality control.
Deacylated alfuzosin
| API Name | Alfuzosin |
|---|---|
| CAS No | 76362-29-3 |
| Molecular Formula | C14H21N5O2 |
| Molecular Weight | 291.35 g/mol |
| Synonyms | 2-N-(3-aminopropyl)-6,7-dimethoxy-2-N-methylquinazoline-2,4-diamine |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
The active drug, alfuzosin, is used to treat symptoms of an enlarged prostate (benign prostatic hyperplasia, or BPH). Deacylated alfuzosin, also known as alfuzosin aminopropyl impurity (Alfuzosin EP Impurity D), has no therapeutic use as a drug itself; it is an inactive metabolite and an impurity standard used in pharmaceutical development and quality control.
The CAS number of Deacylated alfuzosin is 76362-29-3.
The molecular formula of Deacylated alfuzosin is C14H21N5O2.
The listed molecular weight of Deacylated alfuzosin is 291.35 g/mol.
Deacylated alfuzosin is listed as being used in connection with the following API: Alfuzosin.
The listed synonym or IUPAC name for Deacylated alfuzosin is 2-N-(3-aminopropyl)-6,7-dimethoxy-2-N-methylquinazoline-2,4-diamine.